A detailed history of Moneta Group Investment Advisors LLC transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, Moneta Group Investment Advisors LLC holds 13,846 shares of ATAI stock, worth $22,292. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,846
Previous 14,254 2.86%
Holding current value
$22,292
Previous $18,000 11.11%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$1.16 - $1.64 $473 - $669
-408 Reduced 2.86%
13,846 $16,000
Q4 2023

Feb 15, 2024

BUY
$1.04 - $1.55 $1,568 - $2,337
1,508 Added 11.83%
14,254 $20,000
Q1 2023

May 15, 2023

BUY
$1.17 - $2.7 $14,912 - $34,414
12,746 New
12,746 $23,000

Others Institutions Holding ATAI

About ATAI Life Sciences N.V.


  • Ticker ATAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 165,875,008
  • Market Cap $267M
  • Description
  • Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...
More about ATAI
Track This Portfolio

Track Moneta Group Investment Advisors LLC Portfolio

Follow Moneta Group Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moneta Group Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moneta Group Investment Advisors LLC with notifications on news.